Ernexa Therapeutics Inc.
ERNA Healthcare Biotechnology
Ernexa Therapeutics Inc.’s revenue for fiscal 2024 (year ended December 2024) was $582,000.00, up 755.9% from fiscal 2023. In the quarter to June 2026, revenue fell 94.1%, EPS grew 77.7% and free cash flow fell 64.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ERNA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
3.26 | — | 1.63 | — | 16.99 | — | 11.45 | 7.58 | 1.73 | 1.88 |
Receivables |
1.20 | 0.12 | 0.12 | — | 0.68 | — | 0.95 | 0.43 | 0.44 | 0.10 |
Other current assets |
1.09 | 0.10 | 0.66 | 1.10 | — | 1.28 | — | — | — | 0.75 |
Total current assets |
6.07 | — | 1.73 | — | 18.77 | — | 13.68 | 9.60 | 2.35 | 3.13 |
Property, Plant, Equpment (Net) |
2.82 | — | 0.59 | — | 0.67 | — | 0.24 | 0.49 | 0.09 | 0.09 |
Software (Capitalized) |
1.92 | — | 1.36 | — | — | — | — | — | — | — |
Long-Term Investments |
— | — | — | — | 1.00 | — | 0.06 | — | — | — |
Goodwill and Intangible Assets (Total) |
0.70 | — | 2.04 | — | 2.04 | — | 2.04 | 2.04 | 2.04 | 2.04 |
Long-term assets (Other) |
0.25 | — | 6.44 | — | 6.48 | — | 5.23 | 4.22 | 0.12 | 0.11 |
Total non-current assets |
8.06 | — | 11.17 | — | 12.76 | — | 8.60 | 39.53 | 2.92 | 2.70 |
Total Assets |
14.13 | — | 12.91 | — | 31.53 | — | 22.28 | 49.13 | 5.27 | 5.83 |
Notes Payable |
— | — | 0.41 | — | — | — | — | — | — | — |
Accounts Payable |
0.84 | — | 1.28 | — | 1.76 | — | 1.62 | 1.07 | 1.72 | 1.13 |
Accrued Expenses |
1.08 | — | 1.05 | — | 1.25 | — | 3.63 | 1.89 | 1.02 | 0.91 |
Current Part of Debt |
2.74 | — | 0.12 | — | — | — | — | — | — | — |
Current Part of Capital Lease |
0.02 | — | 0.02 | — | — | — | — | — | — | — |
Current Part of Taxes to Pay |
0.13 | — | 0.02 | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Current Revenue (Deferred) |
0.46 | — | 0.08 | — | — | — | 0.00 | 0.19 | 0.00 | — |
Other current liabilities |
0.42 | 1.05 | 0.14 | — | 0.25 | — | 0.36 | — | — | 0.12 |
Total current liabilities |
6.10 | — | 3.13 | — | 3.68 | — | 7.65 | 6.57 | 2.94 | 3.11 |
Long Term Debt (Total) |
0.02 | — | 0.19 | 2.30 | — | 0.89 | — | 6.77 | — | — |
Non-current Revenue (Deferred) |
0.00 | 0.00 | 0.00 | — | — | — | — | 0.39 | 0.00 | — |
Non-current Liabilities (Other) |
0.03 | — | 0.02 | — | 0.05 | — | 1.63 | 0.31 | 0.15 | 0.04 |
Total non-current liabilities |
2.94 | — | 2.12 | — | 2.35 | — | 2.52 | 40.33 | 0.63 | 0.32 |
Total liabilities |
9.03 | — | 5.25 | — | 6.02 | — | 10.17 | 46.90 | 3.57 | 3.43 |
Additional Paid In Capital |
136.72 | — | 0.00 | — | 166.19 | — | 177.38 | 189.19 | 233.22 | 248.00 |
Preferred Stock (Total) |
0.00 | — | 0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock (Net) |
0.01 | — | 25.80 | — | 0.01 | — | 0.03 | 0.03 | 0.02 | 0.04 |
Retained Earnings |
(131.46) | — | (18.14) | — | (140.70) | — | (165.30) | (186.98) | (231.54) | (245.64) |
Treasury Stock |
0.46 | — | 0.46 | — | — | — | — | — | — | — |
Common Equity (Total) |
5.09 | — | 7.66 | — | 25.50 | — | 12.11 | 2.23 | 1.70 | 2.40 |
Shareholders Equity (Total) |
5.09 | — | 7.66 | — | 25.50 | — | 12.11 | 2.23 | 1.70 | 2.40 |
Shareholders Equity and Liabilities (Total) |
14.13 | — | 12.91 | — | 31.53 | — | 22.28 | 49.13 | 5.27 | 5.83 |
Shares (Common) |
0.00 | — | 1.48 | — | 0.01 | — | 0.01 | 0.01 | 0.14 | 0.31 |
Shares (Preferred) |
0.00 | — | 0.08 | — | 0.00 | — | 0.00 | 0.00 | 0.01 | 0.01 |
Shareholders Equity (Tangible) |
4.40 | — | 5.62 | — | 23.46 | — | 10.06 | 0.19 | (0.34) | 0.36 |
Net Debt |
(0.50) | 1.27 | (1.32) | 2.30 | (16.98) | 0.89 | (11.45) | (0.80) | (1.73) | (1.88) |
Total Debt |
2.76 | 2.90 | 0.31 | 2.30 | — | 0.89 | — | 6.77 | — | — |